MINERALYS THERAPEUTICS
Mineralys Therapeutics is a biopharmaceutical company that provides hypertension treatment. They also bring a targeted approach to the management of hypertension.
MINERALYS THERAPEUTICS
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2020-01-01
Address:
Radnor, Pennsylvania, United States
Country:
United States
Website Url:
http://www.mineralystx.com
Total Employee:
1+
Status:
Active
Contact:
+1 610 977 2000
Total Funding:
162 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Wordpress Plugins
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Arcutis Biotherapeutics
Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.
Arrakis Therapeutics
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Zentalis Pharmaceuticals
Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.
Current Advisors List
Board_member
2022-06-08
Board_member
2022-06-08
Board_member
Board_member
Current Employees Featured
David Rodman Chief Medical Officer @ Mineralys Therapeutics
Chief Medical Officer
2021-04-01
Adam Levy CFO & CBO @ Mineralys Therapeutics
CFO & CBO
2022-03-01
Jon Congleton Chief Executive Officer @ Mineralys Therapeutics
Chief Executive Officer
2020-11-01
Founder
Investors List
Boulder Ventures
Boulder Ventures investment in Series B - Mineralys Therapeutics
Catalys Pacific
Catalys Pacific investment in Series B - Mineralys Therapeutics
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series B - Mineralys Therapeutics
SR One
SR One investment in Series B - Mineralys Therapeutics
Andera Partners
Andera Partners investment in Series B - Mineralys Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Series B - Mineralys Therapeutics
HealthCor Partners
HealthCor Partners investment in Series B - Mineralys Therapeutics
Adams Street Partners
Adams Street Partners investment in Series B - Mineralys Therapeutics
Ysios Capital
Ysios Capital investment in Series B - Mineralys Therapeutics
RTW Investments LLC
RTW Investments LLC investment in Series B - Mineralys Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-15 | Mineralys Therapeutics Appoints Adam Levy as Chief Financial Officer and Chief Business Officer |
Official Site Inspections
http://www.mineralystx.com Semrush global rank: 5.63 M Semrush visits lastest month: 1.5 K
- Host name: 88.227.196.104.bc.googleusercontent.com
- IP address: 104.196.227.88
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Mineralys Therapeutics"
About – Mineralys Therapeutics
Prior to joining Mineralys, he was the Chief Financial Officer at Sanifit Therapeutics until the company was acquired by Vifor Pharma in 2022. Previously, Adam served as the Chief …See details»
Mineralys Therapeutics – A targeted approach for the control of ...
We are focused on improving outcomes for people managing hypertension, CKD and related diseases that are driven by dysregulated aldosterone.See details»
Company Information :: Mineralys Therapeutics, Inc. (MLYS)
Company Contact Mineralys Therapeutics, Inc. 150 N. Radnor Chester Rd Suite F200 Radnor, PA 19087 United States Toll-Free: 888-378-6240See details»
Mineralys Therapeutics - Crunchbase Company Profile …
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.See details»
Mineralys Therapeutics, Inc. (MLYS)
Nov 4, 2024 investorrelations@mineralystx.com. Transfer Agent. American Stock Transfer & Trust Company LLC 6201 15th Avenue Brooklyn, New York 11219 United States T: 800-937-5449 F: 718-236-2641 …See details»
Mineralys Therapeutics, Inc. | LinkedIn
Mineralys Therapeutics, Inc. Biotechnology Research Radnor, PA 7,537 followers Public, clinical-stage biopharmaceutical company committed to developing best-in-class, novel therapy for …See details»
Contact Us – Mineralys Therapeutics
In our most recent survey, 93% of employees said Mineralys is a Great Place to Work®. We know the work doesn’t stop there, though, and continue to focus on nurturing strong connections between team members, high levels of trust …See details»
Mineralys Therapeutics, Inc. (MLYS) - Yahoo Finance
See the company profile for Mineralys Therapeutics, Inc. (MLYS) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Mineralys Therapeutics - Overview, News & Similar companies
Mineralys Therapeutics contact info: Phone number: (888) 378-6240 Website: www.mineralystx.com What does Mineralys Therapeutics do? Mineralys Therapeutics is a …See details»
Contacts :: Mineralys Therapeutics, Inc. (MLYS)
Investorrelations@mineralystx.com. Transfer Agent. American Stock Transfer & Trust Company LLC 6201 15th Avenue Brooklyn, New York 11219 United States T: 800-937-5449 F: 718-236 …See details»
Mineralys Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Contact:Investor Relationsinvestorrelations@mineralystx.com Media RelationsTom WeibleElixir Health Public RelationsPhone: (1) 515-707-9678Email: tweible@elixirhealthpr.com . ... The …See details»
Mineralys Therapeutics - VentureRadar
Similar Companies: Agastiya Biotech USA n/a Over 40% of all pharmaceutical drugs, including sophisticated chemotherapy and anti-viral drugs, are derived from natural plant sources. …See details»
Mineralys Therapeutics to Participate in Upcoming Investor …
Nov 5, 2024 Mineralys is based in Radnor, Pennsylvania, and was founded by Catalys Pacific. For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn and …See details»
Mineralys Therapeutics Inc. - Cruelty Free Investing
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and chronic kidney diseases. It clinical-stage product …See details»
Mineralys Therapeutics Appoints Adam Levy as Chief Financial …
Mar 15, 2022 His prior appointments include serving as CBO at Brickell Biotech Inc. where he led the organization's financial operations transition as it became a publicly listed company on …See details»
Careers API – Mineralys Therapeutics
At the heart of our company is a diverse and highly experienced team that embodies passion, drive, and curiosity. Our members come from a range of backgrounds, bringing unique …See details»
Mineralys Therapeutics Reports Third Quarter 2024 Financial …
Nov 11, 2024 For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn and Twitter. Forward Looking Statements. Mineralys Therapeutics cautions you that …See details»
Science – Mineralys Therapeutics
Lorundrostat targets aldosterone-driven hypertension by inhibiting the enzyme that catalyzes the final steps of aldosterone synthesis. Our goal is to decrease levels of aldosterone by …See details»
Mineralys Therapeutics Completes Enrollment Ahead of Schedule …
Oct 30, 2024 investorrelations@mineralystx.com. Media Relations Tom Weible Elixir Health Public Relations Phone: (1) 515-707-9678 Email: tweible@elixirhealthpr.com. Source: …See details»
Pipeline – Mineralys Therapeutics
An ongoing, randomized, double-blind, placebo-controlled, parallel arm, multicenter, phase 3 trial to evaluate the blood pressure-lowering effects of lorundrostat in adults with uncontrolled …See details»